Loading clinical trials...
Loading clinical trials...
Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Relief of Nasal Congestion Associated With Seasonal Allergic Rhinitis (SAR)
Conditions
Interventions
Mometasone furoate nasal spray (MFNS)
Matching placebo nasal spray
Start Date
August 1, 2008
Primary Completion Date
October 1, 2008
Completion Date
October 1, 2008
Last Updated
February 9, 2022
NCT06732414
NCT05494346
NCT06061848
NCT06603935
NCT06151938
NCT05186025
Lead Sponsor
Organon and Co
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions